Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT

Tango Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-145.57M -132.26M -130.3M -123.39M -116.49M -111.65M -101.74M -100.04M -106.83M -110.98M -108.18M -101.16M -91.7M -71.34M -58.23M -45.05M -52.27M -56.16M
Depreciation & Amortization
2.49M 2.5M 2.5M 2.5M 2.49M 2.46M 2.42M 2.37M 2.17M 1.88M 1.61M 1.29M 1.1M 1M 897K 832K 793K 758K
Stock-Based Compensation
28.46M 29.43M 28.9M 26.31M 24M 21.58M 19.08M 17.98M 16.94M 15.24M 14.23M 12.7M 12.32M 10.09M 7.83M 6.11M 3.1M 2.31M
Other Working Capital
-19.46M -34.34M -30.56M -26.58M -25.82M -30.89M -38.26M -40.54M -26.35M -26.8M -19.59M -20.37M -19.29M -15.46M -12.96M -16.38M -15.83M -9.51M
Other Non-Cash Items
-14.72M -75K -849K -2.39M -470K -210K 234K 2.1M 1.01M 1.32M 1.75M 1.74M 1.46M 1.44M 1.32M 1.25M 136.63M 131.74M
Deferred Income Tax
n/a n/a n/a -2.36M -1.63M -3.39M -3.39M -1.03M -1.77M n/a n/a 0.00 0.00 0.00 0.00 n/a n/a n/a
Change in Working Capital
-18.93M -34.93M -31.75M -25.35M -29.59M -33.11M -37.97M -41.19M -20.55M -21.79M -18.49M -12.29M -22.78M -16.77M -11.35M -23.82M -16.18M -10.05M
Operating Cash Flow
-148.25M -135.34M -131.5M -122.32M -120.07M -120.93M -117.98M -118.78M -107.26M -114.32M -109.08M -97.72M -99.6M -75.58M -59.53M -60.69M 72.07M 68.59M
Capital Expenditures
-914K -610K -754K -856K -757K -1.1M -1.53M -2.34M -5.6M -6.75M -7.69M -7.35M -4.84M -3.23M -1.84M -1.6M -955K -1.24M
Cash Acquisitions
n/a n/a n/a -34.08M 22.57M -10.78M -42.95M 2.69M -72.47M -76.42M -44.25M -55.78M -37.27M -0.49 -0.49 166.68M 166.68M 166.71M
Purchase of Investments
-143.11M -167.79M -240.89M -259.36M -376.14M -378.3M -310.57M -353.11M -241.32M -206.47M -208.5M -219.33M -356.74M -407.06M -372.36M -373.57M -191.71M -125.47M
Sales Maturities Of Investments
276.03M 296.32M 327.77M 328.14M 355.58M 378.08M 353.53M 350.42M 313.79M 282.88M 242.59M 220.48M 187.93M 194.53M 190.76M 177.77M 147.35M 87.53M
Other Investing Acitivies
n/a n/a n/a 34.08M -22.57M 10.78M 42.95M -2.69M 72.47M 76.42M 34.09M 45.62M 27.12M -10.16M 20.78M -145.94M -215.56M -243.5M
Investing Cash Flow
132M 127.93M 86.13M 67.92M -21.32M -1.33M 41.43M -5.03M 66.86M 69.67M 26.4M -6.2M -173.65M -215.76M -183.43M -197.44M -114.97M -136.74M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.95M 4.68M 5.94M 6.44M 4.48M 3.75M 2.57M 1.63M 1.3M 1.43M 1.61M 968K 328.63M 327.17M 327.33M 327.39M 50.69M 81.3M
Financial Cash Flow
3.95M 4.68M 47.66M 48.16M 126.04M 125.31M 82.41M 81.47M 1.3M 1.43M 1.61M 968K 328.63M 327.17M 357.32M 357.38M 80.69M 111.3M
Net Cash Flow
-12.29M -2.73M 2.29M -6.24M -15.34M 3.06M 5.85M -42.35M -39.1M -43.22M -81.07M -102.95M 55.39M 35.83M 114.36M 99.26M 37.78M 43.14M
Free Cash Flow
-149.17M -135.95M -132.25M -123.18M -120.82M -122.03M -119.51M -121.12M -112.86M -121.07M -116.77M -105.06M -104.44M -78.81M -61.36M -62.28M 71.11M 67.35M